Kymanox
58 Case Studies
A Kymanox Case Study
The Client, a pharmaceutical company, faced significant regulatory and technical challenges in developing a synthetic peptide nasal spray for a rare disease. These hurdles included aligning product development with global standards and reviving an FDA-rejected application. They engaged Kymanox for assistance with clinical and medical affairs, regulatory affairs, and product development services to overcome these obstacles.
Kymanox implemented a comprehensive solution involving enhanced analytical techniques, process optimization, and Design History File remediation. This effort standardized testing, increased manufacturing yields, and established new particulate matter standards for nasal sprays. As a result, Kymanox helped secure commercial manufacturing partners and successfully initiated international clinical studies, advancing the product toward multi-regional approval for the orphan indication.
The Client